October Pharma, Egypt sees 39% YoY profit increase in 2023

Getty Images

Likewise, net sales surged to EGP 1.011 billion last year from EGP 727.37 million a year earlier

Staff Writer, Arab Finance

March 11, 2024

PHOTO

October Pharma’s (OCPH) net profits after tax rose by 39.3% year on year in 2023 to EGP 182.132 million, compared to EGP 130.747 million, as per a statement.

Likewise, net sales surged to EGP 1.011 billion last year from EGP 727.37 million a year earlier.

October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.

The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.